News Breathing space for GSK as Mylan's Advair copy rejected Stay of execution for ageing blockbuster
News Mylan recalls 81,000 EpiPens after reports of failures Recall follows two reports that allergy injection device failed.
News A re-brand for US generics and biosimilars sector Body will campaign to "Keep Medicines in Reach"
News Use generic alternatives to Seretide and save millions, advi... Earlier use of montelukast could save NHS millions, says NICE.
News Novo completes $16.5bn takeover of Catalent Novo Holdings' $16.5bn takeover of US CDMO Catalent has been completed, after months of debate over potential antitrust issues.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
